11^th European Biosimilars Congress

Emile Van Corven pursued MSc in Biology/Chemistry at Leiden University, Netherlands. He got his PhD in 1987 at Nijmegen University and was a Postdoc Fellow at The Netherlands Cancer Institute in Amsterdam, Netherlands. He is currently the Chief Development Officer at Bioceros, Head of Downstream Process and Analytical Development. He has a track record of more than 25 years in the biopharmaceutical industry: Principal Consultant CMC (Xendo), Director and Global Head of process development and pilot plant GMP manufacturing of vaccines (Crucell/J&J), and development of recombinant proteins (Pharming). He also worked for the Dutch Regulatory Authorities as Head of Control Lab for the Release Of Blood Products/Vaccines, and Head of the Regulatory Group for review of Biotech CMC Dossiers. He has published over 30 peer-reviewed scientific articles, chapters in textbooks, and is Co-inventor of various patents. From 2012-2015, he was a Member of the Editorial Board of Pharmaceutical Bioprocessing.